Last reviewed · How we verify
NCT07488052: HOME-ECG
Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG)
trial testing Single-Lead ECG Acquisition [Apple Watch and QOCA ECG102D] in Heart Failure in 5,000 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | National Defense Medical Center, Taiwan |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 March 2026 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 September 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Single-Lead ECG Acquisition [Apple Watch and QOCA ECG102D]
Conditions studied
- Heart Failure — all drugs for Heart Failure →
Sponsor
National Defense Medical Center, Taiwan
Who can join
Adults 20 to 90, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective multicenter observational study will validate the accuracy of a previously developed artificial intelligence-enabled single-lead electrocardiogram (AI-ECG) model for identifying low ejection fraction and other structural heart disease phenotypes. Adult participants receiving a model-compatible single-lead electrocardiogram (ECG) (Apple Watch and QOCA ECG102D) and transthoracic echocardiography at five hospitals in Taiwan will be enrolled between March 1, 2026 and June 30, 2026. Model predictions will be compared with echocardiographic reference standards obtained within 30 days after the index ECG.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07488052
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other National Defense Medical Center, Taiwan trials
Trials by the same sponsor.
- NCT07373002 — Development and Evaluation of an Intelligent Parent-Infant Connection-Based Intervention to Strengthen Family Resilience · NA · not yet recruiting
- NCT07307729 — AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emu · NA · not yet recruiting
- NCT07217236 — Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG · NA · recruiting
- NCT06887699 — The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value- · NA · recruiting
- NCT06847932 — Leveraging AI-ECG Technology for Early Notification and Tracking of AF Development · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07488052 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Defense Medical Center, Taiwan
- Last refreshed: 25 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07488052.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing